MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to fall 327.00% to 47 cents per share on July 31

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q2'25
Est.
$0.48
Q1'25
Missed
by $0.58
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.25
Q2'24
Beat
by $0.37
The last earnings report on May 06 showed earnings per share of -20 cents, missing the estimate of 37 cents. With 119.07K shares outstanding, the current market capitalization sits at 1.84B.
View a ticker or compare two or three
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com